The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000212.2(ITGB3):c.1299C>T (p.Pro433=)

CA8623241

323866 (ClinVar)

Gene: ITGB3
Condition: Glanzmann thrombasthenia
Inheritance Mode: Autosomal recessive inheritance
UUID: 77c51cf2-073d-4123-9bca-809de4125661
Approved on: 2023-12-19
Published on: 2023-12-19

HGVS expressions

NM_000212.2:c.1299C>T
NM_000212.2(ITGB3):c.1299C>T (p.Pro433=)
NC_000017.11:g.47292177C>T
CM000679.2:g.47292177C>T
NC_000017.10:g.45369543C>T
CM000679.1:g.45369543C>T
NC_000017.9:g.42724542C>T
NG_008332.2:g.43336C>T
ENST00000559488.7:c.1299C>T
ENST00000559488.5:c.1299C>T
ENST00000560629.1:c.1264C>T
NM_000212.3:c.1299C>T
NM_000212.3(ITGB3):c.1299C>T (p.Pro433=)
More

Likely Benign

Met criteria codes 3
BS1 BP7 BP4
Not Met criteria codes 1
BS2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
The NM_000212.2(ITGB3):c.1299C>T (p.Pro433=) synonymous variant was observed by Illumina as part of a predisposition screen in an ostensibly healthy population and has been reported in the literature in a healthy cohort (PMID: 27965976) but has not been reported in a Glanzmann thrombasthenia patient. In gnomAD v4.0.0 the minor allele frequency is 0.001910 (174/91086 alleles) in the South Asian population, which meets the BS1 threshold (>0.00158). Splicing prediction algorithms (MaxEntScan, HSF, and SpliceAI) predict no impact on splicing (BP4) and the nucleotide is not highly conserved (phyloP score 0.129449; BP7). In summary this variant meets criteria to be classified as likely benign. GT-specific criteria applied: BS1, BP4 and BP7.
Met criteria codes
BS1
The highest population minor allele frequency in gnomAD v4.0.0 is 0.002969 (18/6062 alleles) in the Middle Eastern population, which is higher than the ClinGen PD VCEP BA1 threshold (>0.0024), due to this being a bottle-necked population this was downgraded to BS1. The next highest minor allele frequency in gnomAD v4.0.0 is 0.001910 (174/91086 alleles) in the South Asian population, which also meets the BS1 threshold (>0.00158).
BP7
Splicing prediction algorithms (MaxEntScan, HSF, and SpliceAI) predict no impact to the splice consensus sequence nor the creation of a new splice site AND the nucleotide is not highly conserved (phyloP score 0.129449).
BP4
Splicing prediction algorithms (MaxEntScan, HSF, and SpliceAI) predict no impact to the splice consensus sequence nor the creation of a new splice site. CADD RawScore 0.645923 and PHRED 10.70.
Not Met criteria codes
BS2
One healthy native Chinese subject, in PMID: 27965976, was identified with this variant however the full genotype and phenotype was not provided for this individual.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.